Similar activity of mecamylamine stereoisomers in vitro and in vivo

European Journal of Pharmacology

Volumn 720, Issue 1-3, 2013, Pages 264-275

  Papke, Roger L ^a   Stokes, Clare ^a   Muldoon, Pretal ^b   Imad Damaj, M ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Depression; Nicotine addiction; TC 2559; TC 5214; Tourette's syndrome

Indexed keywords

MECAMYLAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA2; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR ALPHA4BETA2; NICOTINIC RECEPTOR ALPHA5; NICOTINIC RECEPTOR ALPHA6; TC 2559; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BINDING KINETICS; BODY TEMPERATURE; DRUG ACTIVITY; DRUG INHIBITION; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; STEREOISOMERISM; XENOPUS;

DEPRESSION; NICOTINE ADDICTION; TC-2559; TC-5214; TOURETTE'S SYNDROME;

ANALGESICS; ANIMALS; HOT TEMPERATURE; HUMANS; MALE; MECAMYLAMINE; MICE; MICE, INBRED ICR; NICOTINIC ANTAGONISTS; OOCYTES; PAIN; PROTEIN SUBUNITS; RECEPTORS, NICOTINIC; STEREOISOMERISM; XENOPUS LAEVIS;

EID: 84890116721     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.10.018     Document Type: Article

References (50)

1. N.L. Benowitz Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics Annu. Rev. Pharmacol. Toxicol. 49 2009 57 71
2. Chini, B., Clementi, F., Hukovic, N., Sher, E., 1992. Neuronal-type alpha-bungarotoxin receptors and the alpha 5- nicotinic receptor subunit gene are expressed in neuronal and nonneuronal human cell lines. Proc. Natl. Acad. Sci. USA 89, pp. 1572-1576.
3. J.W. Coe, P.R. Brooks, M.G. Vetelino, M.C. Wirtz, E.P. Arnold, J. Huang, S.B. Sands, T.I. Davis, L.A. Lebel, C.B. Fox, A. Shrikhande, J.H. Heym, E. Schaeffer, H. Rollema, Y. Lu, R.S. Mansbach, L.K. Chambers, C.C. Rovetti, D.W. Schulz, F.D. Tingley 3rd, and B.T. O'Neill Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation J. Med. Chem. 48 2005 3474 3477 (Pubitemid 40664098)
4. M.I. Damaj, W. Glassco, M. Dukat, and B.R. Martin Pharmacological characterization of nicotine-induced seizures in mice J. Pharmacol. Exp. Ther. 291 1999 1284 1291
5. M.I. Damaj, S.P. Welch, and B.R. Martin Involvement of calcium and L-type channels in nicotine-induced antinociception J. Pharmcol. Exp. Ther. 266 1993 1330 1338 (Pubitemid 24175776)
6. M.I. Damaj, S.P. Welch, and B.R. Martin In vivo pharmacological effects of dihydro-beta-erythroidine, a nicotinic antagonist, in mice Psychopharmacology (Berl.) 117 1995 67 73
7. F.E. D'Amour, and D.L. Smith A method for determining loss of pain sensation J. Pharmacol. Exp. Ther. 72 1941 74 79
8. E.W. Dennis, R.V. Ford, J.H. Moyer, and R.L. Hershberger Mecamylamine in the treatment of hypertension J. Med. Assoc. Ga. 46 1957 427 430
9. N.B. Fedorov, L.C. Benson, J. Graef, P.M. Lippiello, and M. Bencherif Differential pharmacologies of mecamylamine enantiomers: positive allosteric modulation and noncompetitive inhibition J. Pharmacol. Exp. Ther. 328 2009 525 532
10. C.D. Fowler, Q. Lu, P.M. Johnson, M.J. Marks, and P.J. Kenny Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake Nature 471 2011 597 601
11. S. Frahm, M.A. Slimak, L. Ferrarese, J. Santos-Torres, B. Antolin-Fontes, S. Auer, S. Filkin, S. Pons, J.F. Fontaine, V. Tsetlin, U. Maskos, and I. Ibanez-Tallon Aversion to nicotine is regulated by the balanced activity of beta4 and alpha5 nicotinic receptor subunits in the medial habenula Neuron 70 2011 522 535
12. C. Gotti, F. Clementi, A. Fornari, A. Gaimarri, S. Guiducci, I. Manfredi, M. Moretti, P. Pedrazzi, L. Pucci, and M. Zoli Structural and functional diversity of native brain neuronal nicotinic receptors Biochem. Pharmacol. 78 2009 703 711
13. D.A. Gurley, A.K. Robbins, P.L. Gunyuzlu, W.C. Moore, and E.C. Johnson Pharmacological properties of nicotinic agonists at the two stoichiometries of the alpha4beta2 and alpha2beta2 receptors, Nicotinic Acetylcholine Receptors 2008 Wellcome Trust, Hinxton UK
14. Z.Y. Han, N. Le Novere, M. Zoli, J.A. Hill Jr., N. Champtiaux, and J.P. Changeux Localization of nAChR subunit mRNAs in the brain of Macaca mulatta Eur. J. Neurosci. 12 2000 3664 3674
15. Z.Y. Han, M. Zoli, A. Cardona, J.P. Bourgeois, J.P. Changeux, and N. Le Novere Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta J. Comp. Neurol. 461 2003 49 60 (Pubitemid 36578596)
16. K. Harpsoe, P.K. Ahring, J.K. Christensen, M.L. Jensen, D. Peters, and T. Balle Unraveling the high- and low-sensitivity agonist responses of nicotinic acetylcholine receptors J. Neurosci. 31 2011 10759 10766
17. K.J. Jackson, M.J. Marks, R.E. Vann, X. Chen, T.F. Gamage, J.A. Warner, and M.I. Damaj Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice J. Pharmacol. Exp. Ther. 334 2010 137 146
18. â nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the alpha5 subunit in the mouse Neuropharmacology 70 2013 228 235
19. â acetylcholine receptors in Xenopus laevis oocytes achieved through subunit chimeras and concatamers Mol. Pharmacol. 79 2011 126 140
20. â) nicotinic receptors Mol. Pharmacol. 74 2008 132 143 (Pubitemid 351872165)
21. C.W. Lindsley (S)-(+)-Mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for major depressive disorder (MDD) ACS Chem. Neurosci. 1 2010 530 531
22. R.J. Lukas, A.Z. Muresan, M.I. Damaj, B.E. Blough, X. Huang, H.A. Navarro, S.W. Mascarella, J.B. Eaton, S.K. Marxer-Miller, and F.I. Carroll Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation J. Med. Chem. 53 2010 4731 4748
23. L.M. Marubio, M. del Mar Arroyo-Jimenez, M. Cordero-Erausquin, C. Lena, N. Le Novere, A. de Kerchove d'Exaerde, M. Huchet, M.I. Damaj, and J.P. Changeux Reduced antinociception in mice lacking neuronal nicotinic receptor subunits Nature 398 1999 805 810
24. N.S. Millar, and C. Gotti Diversity of vertebrate nicotinic acetylcholine receptors Neuropharmacology 56 2009 237 246
25. C. Miller Genetic manipulation of ion channels: a new approach to structure and mechanism Neuron 2 1989 1195 1205
26. Y.S. Mineur, C. Eibl, G. Young, C. Kochevar, R.L. Papke, D. Gundisch, and M.R. Picciotto Cytisine-based nicotinic partial agonists as novel antidepressant compounds J. Pharmacol. Exp. Ther. 329 2009 377 386
27. R.L. Papke Tricks of Perspective: Insights and limitations to the study of macroscopic currents for the analysis of nAChR activation and desensitization J. Mol. Neurosci. 40 2010 77 86
28. R.L. Papke, L.P. Dwoskin, and P.A. Crooks The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery J. Neurochem. 101 2007 160 167 (Pubitemid 46426475)
29. R.L. Papke, L.P. Dwoskin, P.A. Crooks, G. Zheng, Z. Zhang, J.M. McIntosh, and C. Stokes Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimeras Neuropharmacology 54 2008 1189 1200
30. R.L. Papke, F. Ono, C. Stokes, J.M. Urban, and R.T. Boyd The nicotinic acetylcholine receptors of zebrafish and an evaluation of pharmacological tools used for their study Biochem. Pharmacol. 84 2012 352 365
31. R.L. Papke, and M.R. Picciotto Nicotine Dependence and Depression, What is the Future for Therapeutics? J. Addict. Res. Ther. 2 2012 (1000e1105)
32. R.L. Papke, P.R. Sanberg, and R.D. Shytle Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes J. Pharmacol. Exp. Ther. 297 2001 646 656 (Pubitemid 32377996)
33. R.L. Papke, L. Wecker, and J.A. Stitzel Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes J. Pharmacol. Exp. Ther. 333 2010 501 518
34. Papke, R.L., Zheng, G., Crooks, P.A., Dwoskin, L.P., 2006. Novel trivalent antagonists with selectivity for alpha- nicotinic acetylcholine receptors, In: Proceedings of the 68th Annual Meeting College on Problems of Drug Dependence, Scottsdale, AZ.
35. R.L. Rabenstein, B.J. Caldarone, and M.R. Picciotto The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice Psychopharmacology (Berl.) 189 2006 395 401 (Pubitemid 44772820)
36. H. Rollema, A. Shrikhande, K.M. Ward, F.D. Tingley 3rd, J.W. Coe, B.T. O'Neill, E. Tseng, E.Q. Wang, R.J. Mather, R.S. Hurst, K.E. Williams, M. de Vries, T. Cremers, S. Bertrand, and D. Bertrand Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence Br. J. Pharmacol. 160 2010 334 345
37. J.E. Rose, F.M. Behm, and E.C. Westman Nicotine-mecamylamine treatment for smoking cessation: the role of pre- cessation therapy Exp. Clin. Psychopharmacol. 6 1998 331 343 (Pubitemid 28393951)
38. P.R. Sanberg, R.D. Shytle, and A.A. Silver Treatment of Tourette's syndrome with mecamylamine Lancet 352 1998 705 706 (Pubitemid 28398711)
39. R. Shytle, D. Sheehan, P.R. Sanberg, and H.R. Arias Neuronal nicotinic receptors as therapeutic targets for mood disorders H.R. Arias, Pharmacology of Nicotinic Acetylcholine Receptors from the Basic and Therapeutic Perspectives 2011 Research Signpost India 187 198
40. Silver, A.A., Shytle, R.D., Sheehan, D.V., Sheehan, K.H., Ramos, A., Sanberg, P.R., 2000. Safety and exploratory study of mecamylamine monotherapy for Tourette's syndrome. In: Neuropharmacology: Proc. Neur.nAChR Symposium New Orleans, November 2-4.
41. A.A. Silver, R.D. Shytle, K.H. Sheehan, D.V. Sheehan, A. Ramos, and P.R. Sanberg Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder J. Am. Acad. Child. Adolesc. Psychiatry 40 2001 1103 1110 (Pubitemid 32803824)
42. A. Singh, D.K. Das, and M.E. Kelley Mecamylamine (Targacept) IDrugs 9 2006 205 217
43. C. Stokes, and R.L. Papke Use of an alpha3-beta4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties Neuropharm 63 2012 538 546
44. J.A. Suchocki, E.L. May, T.J. Martin, C. George, and B.R. Martin Synthesis of 2-exo- and 2-endo-mecamylamine analogues. Structure-activity relationships for nicotinic antagonism in the central nervous system J. Med. Chem. 34 1991 1003 1010
45. R.J. Tallarida, and R.B. Murray Manual of Pharmacological Calculations with Computer Programs 1987 Springer-Verlag New York
46. D. Timmermann, K. Sandager-Nielsen, T. Dyhring, M. Smith, A.M. Jacobsen, E. Nielsen, M. Grunnet, J. Christensen, D. Peters, K. Kohlhaas, G. Olsen, and P. Ahring Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of alpha2- and alpha4-containing nicotinic acetylcholine receptors Br. J. Pharmacol. 167 2012 164 182
47. E. Wada, K. Wada, J. Boulter, E. Deneris, S. Heinemann, J. Patrick, and L.W. Swanson Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat J. Comp. Neurol. 284 1989 314 335 (Pubitemid 19185398)
48. J.C. Webster, M.M. Francis, J.K. Porter, G. Robinson, C. Stokes, B. Horenstein, and R.L. Papke Antagonist activities of mecamylamine and nicotine show reciprocal dependence on beta subunit sequence in the second transmembrane domain Br. J. Pharmacol. 127 1999 1337 1348 (Pubitemid 29358934)
49. Y. Zhou, M.E. Nelson, A. Kuryatov, C. Choi, J. Cooper, and J. Lindstrom Human alpha4beta2 acetylcholine receptors formed from linked subunits J. Neurosci. 23 2003 9004 9015 (Pubitemid 37243801)
50. R. Zwart, L.M. Broad, Q. Xi, M. Lee, M. Moroni, I. Bermudez, and E. Sher 5-I A-85380 and TC-2559 differentially activate heterologously expressed alpha4beta2 nicotinic receptors Eur. J. Pharmacol. 539 2006 10 17 (Pubitemid 43796324)